In the wake of Thermo Fisher Scientific, Inc.’s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher’s $1.3 billion takeover bid. With this ...

Look here for a clue. There's no foolproof way to know the future for Affymetrix (Nasdaq: AFFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- ...

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...

On June 25, genetic products maker Affymetrix Inc (AFFX) completed its acquisition of eBioscience Holding Company, Inc. for $315 million in cash. The payment was partly financed through available cash ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics ® Corporation for $15 ...

(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...

SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...

Affymetrix expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Affymetrix' ...

Affymetrix Inc. of Santa Clara won the race Thursday to market a single gene chip packed with fragments from each of the 35,000 known genes that make up the human genome. But two other Bay area ...

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...